Inventor · disambiguated record
Derek Cecil Cole
Also filed as: COLE DEREK · COLE DEREK C · COLE DEREK CECIL
44 granted patents·22 pending applications·610 citations·filing 1998–2024
98Inventor score
Files withWYETH CORP40WYETH LLC8AMERICAN CYANAMID CO4ENDOSOME THERAPEUTICS INC3TAKEDA PHARMACEUTICALS CO3
Top patents by PatentIndex Score
66 records- 0197US6225311B1Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted May 1, 2001·90 cites·13 claims
- 0294US6340691B1Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Jan 22, 2002·42 cites·5 claims
- 0393US6610734B2Heterocyclic sulfonamide inhibitors of beta amyloid productionWYETH CORP·Filed 2001·Granted Aug 26, 2003·53 cites·94 claims
- 0492US6878742B2Heterocyclic sulfonamide inhibitors of beta amyloid productionWYETH CORP·Filed 2003·Granted Apr 12, 2005·40 cites·7 claims
- 0591US7300951B2Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereofWYETH CORP·Filed 2004·Granted Nov 27, 2007·43 cites·30 claims
- 0691US6767912B2Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2001·Granted Jul 27, 2004·34 cites·17 claims
- 0790US7488832B2Azolylacylguanidines as β-secretase inhibitorsWYETH CORP·Filed 2006·Granted Feb 10, 2009·19 cites·8 claims
- 0889US7034029B21-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Apr 25, 2006·23 cites·13 claims
- 0988US7282495B21-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2006·Granted Oct 16, 2007·8 cites·10 claims
- 1088US7166622B2Substituted phenylsulfonamide inhibitors of beta amyloid productionARQULE INC·Filed 2003·Granted Jan 23, 2007·26 cites·17 claims
- 1187US7585876B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Sep 8, 2009·8 cites·6 claims
- 1286US6800764B2Process for the synthesis of chirally pure beta-amino-alcoholsWYETH CORP·Filed 2002·Granted Oct 5, 2004·17 cites·47 claims
- 1386US6770642B2Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2002·Granted Aug 3, 2004·23 cites·19 claims
- 1485US7041695B2N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted May 9, 2006·19 cites·14 claims
- 1584US6951881B2(1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Oct 4, 2005·21 cites·19 claims
- 1683US7547725B2Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereofWYETH CORP·Filed 2007·Granted Jun 16, 2009·6 cites·30 claims
- 1783US6903112B2Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Jun 7, 2005·14 cites·13 claims
- 1882US6906095B2Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Jun 14, 2005·17 cites·14 claims
- 1981US7297705B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Nov 20, 2007·8 cites·6 claims
- 2081US6342508B1N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 2000·Granted Jan 29, 2002·10 cites·12 claims
- 2180US7691884B2Heterocyclic sulfonamide inhibitors of β amyloid productionWYETH CORP·Filed 2005·Granted Apr 6, 2010·3 cites·16 claims
- 2278US7858658B2Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereofWYETH LLC·Filed 2009·Granted Dec 28, 2010·2 cites·5 claims
- 2378US7022701B2Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Apr 4, 2006·10 cites·9 claims
- 2478US6800640B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2002·Granted Oct 5, 2004·9 cites·14 claims
- 2578US6716833B2Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitorsWYETH CORP·Filed 2003·Granted Apr 6, 2004·6 cites·18 claims
- 2677US7220756B2N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2006·Granted May 22, 2007·2 cites·15 claims
- 2776US7842718B2Heterocyclic sulfonamide inhibitors of beta amyloid productionWYETH LLC·Filed 2009·Granted Nov 30, 2010·1 cites·12 claims
- 2876US7557098B21-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Jul 7, 2009·1 cites·20 claims
- 2976US7541370B21-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Jun 2, 2009·1 cites·20 claims
- 3073US7671079B2Sulfonyltetrahydro-3H-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2007·Granted Mar 2, 2010·1 cites·13 claims
- 3173US7671075B2Substituted phenylsulfonamide inhibitors of beta amyloid productionWYETH CORP·Filed 2006·Granted Mar 2, 2010·1 cites·12 claims
- 3272US6172057B1N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitorsAMERICAN CYANAMID CO·Filed 1998·Granted Jan 9, 2001·36 cites·23 claims
- 3371US7820825B2N-substituted-azacyclylamines as histamine-3 antagonistsWYETH LLC·Filed 2007·Granted Oct 26, 2010·1 cites·11 claims
- 3471US7291736B2Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Nov 6, 2007·4 cites·7 claims
- 3570US6812227B2Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitorsWYETH CORP·Filed 2003·Granted Nov 2, 2004·4 cites·18 claims
- 3669US2025235544A1Tripartite Modulators of Endosomal G Protein-Coupled ReceptorsENDOSOME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3768US7288561B2Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Oct 30, 2007·3 cites·14 claims
- 3866US2025064996A1Stabilized compositions of radionuclides and uses thereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 3963US7420001B2Biaryl sulfonamides and methods for using sameWYETH CORP·Filed 2004·Granted Sep 2, 2008·2 cites·16 claims
- 4062US2022227830A1Qd dosing of gip receptor agonist peptide compounds and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 4161US11324832B2Tripartite modulators of endosomal G protein-coupled receptorsENDOSOME THERAPEUTICS INC·Filed 2016·Granted May 10, 2022·1 cites·10 claims
- 4261US2023119819A1Tripartite Modulators of Endosomal G Protein-Coupled ReceptorsENDOSOME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4361US2023158179A1Radiopharmaceutical conjugate compositions and uses thereofRAYZEBIO INC·Filed 2022·Application pending·0 cites
- 4460US6825354B2Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitorsWYETH CORP·Filed 2001·Granted Nov 30, 2004·1 cites·5 claims
- 4558US7608717B2Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Oct 27, 2009·0 cites·9 claims
- 4656US2005113346A1Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitorsWYETH CORP·Filed 2004·Application pending·0 cites
- 4756US2003008849A1Acetylenic alpha -amino acid-based sulfonamide hydroxamic acid tace inhibitorsFiled 2000·Application pending·0 cites
- 4856US2023143604A1Qw dosing of gip receptor agonist peptide compounds and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 4956US2008287424A1AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORSWYETH CORP·Filed 2008·Application pending·0 cites
- 5055US2004132741A11-Aryl-or 1-alkylsulfonyl-heterocyclybenzoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →